Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the website revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check33 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry, v3.7.0, was added to the study record history. The previous revision, v3.6.6, was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe history now shows a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This marks an update to the study record's version in the history.SummaryDifference0.1%

- Check89 days agoChange DetectedThe history list now shows a new revision tag v3.6.5, while the previous v3.6.4 tag is removed, indicating an updated documentation version of the record.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.